NCT06293989 (Vertigo) is a Phase 3 clinical trial of Diazepam 5mg in Vertigo, Peripheral, sponsored by University of Monastir.

Who is sponsoring NCT06293989?

NCT06293989 is sponsored by University of Monastir.

What drugs are being tested in NCT06293989?

Interventions in NCT06293989: Diazepam 5mg, Diazepam 10 mg, Placebo.

What condition does NCT06293989 study?

NCT06293989 studies Vertigo, Peripheral.

Is NCT06293989 still recruiting?

NCT06293989 is currently not yet recruiting. Last updated 2 April 2024.

Last reviewed 2024-04-02 · How we verify

NCT06293989: Vertigo

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy and Safety of Intravenous Diazepam Given at 2 Different Doses Compared to Placebo in Acute Peripheral Vertigo

Not yet recruiting Phase 3 Last updated 2 April 2024

What this trial tests

Phase 3 trial testing Diazepam 5mg in Vertigo, Peripheral in 1,000 participants. Not yet recruiting.

Timeline

1 May 2024

Primary endpoint
30 December 2025

30 March 2026

Quick facts

Lead sponsor	University of Monastir
Phase	Phase 3
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	1,000
Start date	1 May 2024
Primary completion	30 December 2025
Estimated completion	30 March 2026

Drugs / interventions tested

Diazepam 5mg — full drug profile →
Diazepam 10 mg — full drug profile →
Placebo

Conditions studied

Vertigo, Peripheral — all drugs for Vertigo, Peripheral →

Sponsor

University of Monastir

Who can join

Adults 18 to 70, any sex, with Vertigo, Peripheral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is prospective, randomised double-blind study that will be conducted in the emergency department of 3 university hospitals (FB Monastir, Sahloul Sousse, and FH Sousse) to compare the efficacy of two doses of diazepam (Valium®) and placebo for the relief of acute periphery vertigo in the ED

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Vertigo, Peripheral

Currently open trials in the same condition.

NCT06228196 — Cohort Study of Clinical and Neuroimaging Characteristics for BPPV Patients in China · recruiting

Other University of Monastir trials

Trials by the same sponsor.

NCT07345156 — Congestion and LActate at diScHarge in Acute Heart Failure · not yet recruiting
NCT07181642 — Diaphragmatic Breathing for Sleep Bruxism in Adults: A Randomized Controlled Trial · NA · completed
NCT06980727 — Comparative Efficacy of IV Dexamethasone vs. Nebulized Salbutamol for Renal Colic Pain in the ED · Phase 3 · not yet recruiting
NCT06900972 — Effect of Colloids Versus Crystalloids on Heart Mechanics: a Double-blind Cross Over Randomized Trial · Phase 3 · enrolling by invitation
NCT06723002 — Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06293989 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Monastir
Last refreshed: 2 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06293989.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing